Np mrd loader

Record Information
Version1.0
Created at2021-01-06 06:56:08 UTC
Updated at2021-07-15 17:36:55 UTC
NP-MRD IDNP0021655
Secondary Accession NumbersNone
Natural Product Identification
Common NameTobramycin
Provided ByNPAtlasNPAtlas Logo
DescriptionTobramycin, also known as tobrex or nebramycin 6, belongs to the class of organic compounds known as 4,6-disubstituted 2-deoxystreptamines. These are 2-deoxystreptamine aminoglycosides that are glycosidically linked to a pyranose of furanose unit at the C4- and C6-positions. In humans, tobramycin is involved in the tobramycin action pathway. Tobramycin is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Tobramycin is found in Apis cerana, Streptoalloteichus hindustanus, Streptomyces, Streptomyces coeruleoaurantiacus and Streptomyces cremeus. It was first documented in 1970 (PMID: 5522239). Based on a literature review a significant number of articles have been published on Tobramycin (PMID: 11000679) (PMID: 11072877) (PMID: 11459219) (PMID: 11478352).
Structure
Data?1624506898
Synonyms
ValueSource
3'-Deoxykanamycin bChEBI
Nebramycin 6ChEBI
Nebramycin factir 6ChEBI
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamineChEBI
TobracinChEBI
TobrexChEBI
Nebramycin factor 6Kegg
TobiKegg
BethkisKegg
O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-a-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamineGenerator
O-3-Amino-3-deoxy-α-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-α-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamineGenerator
TOBHMDB
SPRC-AB01HMDB
Tobramycin solution for inhalationHMDB
Tobramycin sulfateHMDB
ObracinHMDB
NebcinHMDB
NebicinHMDB
BrulamycinHMDB
Sulfate, tobramycinHMDB
Chemical FormulaC18H37N5O9
Average Mass467.5145 Da
Monoisotopic Mass467.25913 Da
IUPAC Name(2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol
Traditional Nametobramycin
CAS Registry NumberNot Available
SMILES
NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
InChI Identifier
InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1
InChI KeyNLVFBUXFDBBNBW-PBSUHMDJSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Apis ceranaLOTUS Database
Streptoalloteichus hindustanusLOTUS Database
StreptomycesNPAtlas
Streptomyces coeruleoaurantiacusLOTUS Database
Streptomyces cremeusLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 4,6-disubstituted 2-deoxystreptamines. These are 2-deoxystreptamine aminoglycosides that are glycosidically linked to a pyranose of furanose unit at the C4- and C6-positions.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbohydrates and carbohydrate conjugates
Direct Parent4,6-disubstituted 2-deoxystreptamines
Alternative ParentsNot Available
SubstituentsNot Available
Molecular FrameworkAliphatic heteromonocyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-3ALOGPS
logP-6.5ChemAxon
logS-0.94ALOGPS
pKa (Strongest Acidic)12.54ChemAxon
pKa (Strongest Basic)9.66ChemAxon
Physiological Charge5ChemAxon
Hydrogen Acceptor Count14ChemAxon
Hydrogen Donor Count10ChemAxon
Polar Surface Area268.17 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity106.69 m³·mol⁻¹ChemAxon
Polarizability47.17 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
NPAtlas IDNPA024722
HMDB IDHMDB0014822
DrugBank IDDB00684
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID33377
KEGG Compound IDC00397
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkTobramycin
METLIN IDNot Available
PubChem Compound36294
PDB IDTOY
ChEBI ID28864
Good Scents IDNot Available
References
General References
  1. Koch KF, Rhoades JA: Structure of nebramycin factor 6, a new aminoglycosidic antibiotic. Antimicrob Agents Chemother (Bethesda). 1970;10:309-13. [PubMed:5522239 ]
  2. Orts Alborch M, Morant Ventura A, Garcia Callejo J, Ferrer Baixauli F, Martinez Beneito MP, Marco Algarra J: [Monitoring drug ototoxicity with distortion products]. Acta Otorrinolaringol Esp. 2000 Jun-Jul;51(5):387-95. [PubMed:11000679 ]
  3. Banerjee SK, Jagannath C, Hunter RL, Dasgupta A: Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein. Life Sci. 2000 Sep 8;67(16):2011-6. doi: 10.1016/s0024-3205(00)00786-4. [PubMed:11072877 ]
  4. Kwon M, Chun SM, Jeong S, Yu J: In vitro selection of RNA against kanamycin B. Mol Cells. 2001 Jun 30;11(3):303-11. [PubMed:11459219 ]
  5. Phillips JA, Bell SC: Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia. Intern Med J. 2001 Jan-Feb;31(1):23-6. doi: 10.1046/j.1445-5994.2001.00010.x. [PubMed:11478352 ]